This article is more than 5 years old. Information may no longer be current.

Nanovis granted 510(k) clearance for FortiCore interbody fusion devices

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Nanovis Spine recently announced it has received U.S. Food and Drug Administration 510(k) clearance for its sterile-packed FortiCore interbody fusion devices.

FortiCore implants offer the benefits of a highly porous titanium scaffold designed for strong, durable integration with a polyetheretherketone (PEEK) core, according to a company press release.

The implant platform has demonstrated positive results in preclinical studies, which Nanovis plans to publish at a suitable future date, according to the release.

FortiCore is the first of three new technology platforms the company intends to introduce to the spine and orthopedic markets.

Reference: www.nanovisinc.com